![](/img/cover-not-exists.png)
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer
Allyson J. Ocean, Paul Christos, Joseph A. Sparano, Dan Matulich, Andreas Kaubish, Abby Siegel, Max Sung, Maureen M. Ward, Nancy Hamel, Igor Espinoza-Delgado, Yun Yen, Maureen E. LaneVolume:
68
Language:
english
Pages:
10
DOI:
10.1007/s00280-010-1481-z
Date:
August, 2011
File:
PDF, 273 KB
english, 2011